2023
DOI: 10.1016/j.redox.2023.102674
|View full text |Cite
|
Sign up to set email alerts
|

ROS promote hyper-methylation of NDRG2 promoters in a DNMTS-dependent manner: Contributes to the progression of renal fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 57 publications
0
2
0
Order By: Relevance
“…ROS attack-induced hydroxylation of methylcytidine generates 5hmC, which disrupts the accurate transmission of genomic methylation patterns ( 44 ). ROS facilitate the hypermethylation of NDRG2 promoters in a manner that is dependent on DNMTs, key enzymes in DNA methylation ( 45 ). Moreover, ROS can induce site-specific hypermethylation by upregulating DNMTs or forming new DNMT-containing complexes ( 43 ).…”
Section: Epigenetic Modification and Art-induced Cardiovascular Dysfu...mentioning
confidence: 99%
“…ROS attack-induced hydroxylation of methylcytidine generates 5hmC, which disrupts the accurate transmission of genomic methylation patterns ( 44 ). ROS facilitate the hypermethylation of NDRG2 promoters in a manner that is dependent on DNMTs, key enzymes in DNA methylation ( 45 ). Moreover, ROS can induce site-specific hypermethylation by upregulating DNMTs or forming new DNMT-containing complexes ( 43 ).…”
Section: Epigenetic Modification and Art-induced Cardiovascular Dysfu...mentioning
confidence: 99%
“…Currently, MitoQ has been validated to delay age-related kidney fibrosis in a mouse aging model and improve vascular dysfunction in patients with chronic kidney failure, suggesting its potential for application in chronic kidney failure patients [189,190]. Mito-TEMPO, an SOD mimic composed of peroxynitrite and TPP coupling, effectively reversed DNA methylation and reduced kidney fibrotic changes in an NDRG2-dependent manner, leading to a notable enhancement in renal function in a rat model of chronic kidney failure [191,192]. Furthermore, mitochondrial-targeted quinone analogs such as SkQ1 and SkQR1, as well as the SOD mimic Mito-CP, have demonstrated renal protective effects in various acute kidney injury models, though their verification in chronic kidney failure models is still pending [193,194].…”
Section: "Stepping On the Brake"-targeting Mitochondrial Oxidative St...mentioning
confidence: 99%